Robeco Institutional Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,694
| Closed | -$311K | – | 934 |
|
|
2024
Q2 | $311K | Hold |
3,694
| – | – | ﹤0.01% | 869 |
|
|
2024
Q1 | $270K | Hold |
3,694
| – | – | ﹤0.01% | 891 |
|
|
2023
Q4 | $264K | Buy |
3,694
+132
| +4% | +$9.43K | ﹤0.01% | 894 |
|
|
2023
Q3 | $213K | Sell |
3,562
-2,139
| -38% | -$128K | ﹤0.01% | 919 |
|
|
2023
Q2 | $411K | Buy |
5,701
+2,139
| +60% | +$154K | ﹤0.01% | 876 |
|
|
2023
Q1 | $262K | Hold |
3,562
| – | – | ﹤0.01% | 915 |
|
|
2022
Q4 | $238K | Buy |
+3,562
| New | +$238K | ﹤0.01% | 908 |
|